192 related articles for article (PubMed ID: 38598696)
21. Ribotypes and antimicrobial susceptibility profiles of clinical Clostridioides difficile isolates: A multicenter, laboratory-based surveillance in Taiwan, 2019-2021.
Tsai CS; Lu PL; Lu MC; Hsieh TC; Chen WT; Wang JT; Ko WC
J Microbiol Immunol Infect; 2024 Apr; 57(2):320-327. PubMed ID: 38135646
[TBL] [Abstract][Full Text] [Related]
22. Haem is crucial for medium-dependent metronidazole resistance in clinical isolates of Clostridioides difficile.
Boekhoud IM; Sidorov I; Nooij S; Harmanus C; Bos-Sanders IMJG; Viprey V; Spittal W; Clark E; Davies K; Freeman J; Kuijper EJ; Smits WK;
J Antimicrob Chemother; 2021 Jun; 76(7):1731-1740. PubMed ID: 33876817
[TBL] [Abstract][Full Text] [Related]
23. High in vitro activity of fidaxomicin against Clostridium difficile isolates from a university teaching hospital in China.
Cheng JW; Yang QW; Xiao M; Yu SY; Zhou ML; Kudinha T; Kong F; Liao JW; Xu YC
J Microbiol Immunol Infect; 2018 Jun; 51(3):411-416. PubMed ID: 28693926
[TBL] [Abstract][Full Text] [Related]
24. Emergence of Clinical Clostridioides difficile Isolates With Decreased Susceptibility to Vancomycin.
Darkoh C; Keita K; Odo C; Oyaro M; Brown EL; Arias CA; Hanson BM; DuPont HL
Clin Infect Dis; 2022 Jan; 74(1):120-126. PubMed ID: 35016207
[TBL] [Abstract][Full Text] [Related]
25. Impact of Oral Metronidazole, Vancomycin, and Fidaxomicin on Host Shedding and Environmental Contamination With Clostridioides difficile.
Turner NA; Warren BG; Gergen-Teague MF; Addison RM; Addison B; Rutala WA; Weber DJ; Sexton DJ; Anderson DJ
Clin Infect Dis; 2022 Mar; 74(4):648-656. PubMed ID: 34017999
[TBL] [Abstract][Full Text] [Related]
26. Fidaxomicin versus metronidazole, vancomycin and their combination for initial episode, first recurrence and severe Clostridioides difficile infection - An observational cohort study.
Polivkova S; Krutova M; Capek V; Sykorova B; Benes J
Int J Infect Dis; 2021 Feb; 103():226-233. PubMed ID: 33188906
[TBL] [Abstract][Full Text] [Related]
27. Antimicrobial activity of LFF571 and three treatment agents against Clostridium difficile isolates collected for a pan-European survey in 2008: clinical and therapeutic implications.
Debast SB; Bauer MP; Sanders IM; Wilcox MH; Kuijper EJ;
J Antimicrob Chemother; 2013 Jun; 68(6):1305-11. PubMed ID: 23420839
[TBL] [Abstract][Full Text] [Related]
28. Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin.
Peláez T; Alcalá L; Alonso R; Rodríguez-Créixems M; García-Lechuz JM; Bouza E
Antimicrob Agents Chemother; 2002 Jun; 46(6):1647-50. PubMed ID: 12019070
[TBL] [Abstract][Full Text] [Related]
29. Molecular epidemiology and antimicrobial susceptibility of human Clostridium difficile isolates from a single institution in Northern China.
Wang B; Lv Z; Zhang P; Su J
Medicine (Baltimore); 2018 Jun; 97(25):e11219. PubMed ID: 29924052
[TBL] [Abstract][Full Text] [Related]
30. A Clostridium difficile Lineage Endemic to Costa Rican Hospitals Is Multidrug Resistant by Acquisition of Chromosomal Mutations and Novel Mobile Genetic Elements.
Ramírez-Vargas G; Quesada-Gómez C; Acuña-Amador L; López-Ureña D; Murillo T; Del Mar Gamboa-Coronado M; Chaves-Olarte E; Thomson N; Rodríguez-Cavallini E; Rodríguez C
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137804
[TBL] [Abstract][Full Text] [Related]
31. Antibacterial activity of ibezapolstat against antimicrobial-resistant clinical strains of
Bassères E; Eubank TA; Begum K; Alam MJ; Jo J; Le TM; Lancaster CK; Gonzales-Luna AJ; Garey KW
Antimicrob Agents Chemother; 2024 Mar; 68(3):e0162123. PubMed ID: 38364016
[TBL] [Abstract][Full Text] [Related]
32. Characteristics of Clostridium difficile isolates and the burden of hospital-acquired Clostridium difficile infection in a tertiary teaching hospital in Chongqing, Southwest China.
Dai W; Yang T; Yan L; Niu S; Zhang C; Sun J; Wang Z; Xia Y
BMC Infect Dis; 2020 Apr; 20(1):277. PubMed ID: 32293302
[TBL] [Abstract][Full Text] [Related]
33. The effect of antibiotic therapy for Clostridioides difficile infection on mortality and other patient-relevant outcomes: a systematic review and meta-analysis.
Stabholz Y; Paul M
Clin Microbiol Infect; 2024 Jan; 30(1):51-58. PubMed ID: 37690610
[TBL] [Abstract][Full Text] [Related]
34. The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011-2014.
Freeman J; Vernon J; Pilling S; Morris K; Nicholson S; Shearman S; Longshaw C; Wilcox MH;
Clin Microbiol Infect; 2018 Jul; 24(7):724-731. PubMed ID: 29066403
[TBL] [Abstract][Full Text] [Related]
35. Defining the vulnerable period for re-establishment of Clostridium difficile colonization after treatment of C. difficile infection with oral vancomycin or metronidazole.
Abujamel T; Cadnum JL; Jury LA; Sunkesula VC; Kundrapu S; Jump RL; Stintzi AC; Donskey CJ
PLoS One; 2013; 8(10):e76269. PubMed ID: 24098459
[TBL] [Abstract][Full Text] [Related]
36. In vitro selection, via serial passage, of Clostridium difficile mutants with reduced susceptibility to fidaxomicin or vancomycin.
Leeds JA; Sachdeva M; Mullin S; Barnes SW; Ruzin A
J Antimicrob Chemother; 2014 Jan; 69(1):41-4. PubMed ID: 23887866
[TBL] [Abstract][Full Text] [Related]
37. A multicenter-based study on epidemiology, antibiotic susceptibility and risk factors of toxigenic Clostridium difficile in hospitalized patients in southwestern Iran.
Sedigh Ebrahim-Saraie H; Heidari H; Amanati A; Bazargani A; Alireza Taghavi S; Nikokar I; Kalantar K; Motamedifar M
Infez Med; 2018 Dec; 26(4):308-315. PubMed ID: 30555133
[TBL] [Abstract][Full Text] [Related]
38. In vitro susceptibility of Clostridium difficile to SMT19969 and comparators, as well as the killing kinetics and post-antibiotic effects of SMT19969 and comparators against C. difficile.
Corbett D; Wise A; Birchall S; Warn P; Baines SD; Crowther G; Freeman J; Chilton CH; Vernon J; Wilcox MH; Vickers RJ
J Antimicrob Chemother; 2015; 70(6):1751-6. PubMed ID: 25652750
[TBL] [Abstract][Full Text] [Related]
39. Molecular epidemiology of
Alves F; Castro R; Pinto M; Nunes A; Pomba C; Oliveira M; Silveira L; Gomes JP; Oleastro M
Front Public Health; 2022; 10():1070258. PubMed ID: 36684930
[TBL] [Abstract][Full Text] [Related]
40. A narrative review of Clostridioides difficile infection in China.
Wu Y; Wang YY; Bai LL; Zhang WZ; Li GW; Lu JX
Anaerobe; 2022 Apr; 74():102540. PubMed ID: 35219837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
